0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Effects of Androgen Administration in Men with the AIDS Wasting Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Steven Grinspoon, MD; Colleen Corcoran, ANP; Hasan Askari, MBBS; David Schoenfeld, PhD; Lisa Wolf, RN; Belton Burrows, MD; Mark Walsh, MS; Douglas Hayden, MA; Kristin Parlman, MSPT; Ellen Anderson, MS, RD; Nesli Basgoz, MD; and Anne Klibanski, MD
[+] Article and Author Information

For author affiliations and current author addresses, see end of text. Acknowledgments: The authors thank Martin Hirsch, MD, for continued support; Benjamin Davis, MD, Howard Heller, MD, and John Doweiko, MD, for help with patient care and recruitment; Andrew Guccione, PhD, Gregory Newbauer, BA, Madeline Costello, PT, Judy Krempin, BS, Maxine Sleeper, BA, and Kristen Lee, BS, for technical assistance; and Karen Hopcia, RN, and the nursing and nutrition staffs of the Massachusetts General Hospital General Clinical Research Center for dedicated patient care. Grant Support: In part by National Institutes of Health grants R01-DK49302, MO1-RR01066, P32-DK07028, and F32-DK09218. Requests for Reprints: Steven Grinspoon, MD, Neuroendocrine Unit, Bulfinch 457B, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114. Current Author Addresses: Drs. Grinspoon and Klibanski and Ms. Corcoran: Neuroendocrine Unit, Bulfinch 457B, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;129(1):18-26. doi:10.7326/0003-4819-129-1-199807010-00005
Text Size: A A A

Background: Development of successful anabolic strategies to reverse the loss of lean body mass is of critical importance to increase survival in men with the AIDS wasting syndrome. Hypogonadism, an acquired endocrine deficiency state characterized by loss of testosterone, occurs in more than half of all men with advanced HIV disease. It is unknown whether testosterone deficiency contributes to the profound catabolic state and loss of lean body mass associated with the AIDS wasting syndrome.

Objective: To investigate the effects of physiologic testosterone administration on body composition, exercise functional capacity, and quality of life in androgen-deficient men with the AIDS wasting syndrome.

Design: Randomized, double-blind, placebo-controlled study.

Setting: University medical center.

Patients: 51 HIV-positive men (age 42 ± 8 years) with wasting (body weight < 90% of ideal body weight or weight loss > 10% of baseline weight) and a free testosterone level less than 42 pmol/L (normal range for men 18 to 49 years of age, 42 to 121 pmol/L [12.0 to 35.0 pg/mL]).

Intervention: Patients were randomly assigned to receive testosterone enanthate, 300 mg, or placebo intramuscularly every 3 weeks for 6 months.

Measurements: Change in fat-free mass was the primary end point. Secondary clinical end points were weight, lean body mass, muscle mass, exercise functional capacity, and change in perceived quality of life. Virologic variables were assessed by CD4 count and viral load.

Results: Compared with patients who received placebo, testosterone-treated patients gained fat-free mass ( −0.6 kg and 2.0 kg; P = 0.036), lean body mass (0.0 kg and 1.9 kg; P = 0.041), and muscle mass ( −0.8 kg and 2.4 kg; P = 0.005). The changes in weight, fat mass, total-body water content, and exercise functional capacity did not significantly differ between the groups. Patients who received testosterone reported benefit from the treatment (P = 0.036), feeling better (P = 0.033), improved quality of life (P = 0.040), and improved appearance (P = 0.021). Testosterone was well tolerated in all patients.

Conclusions: Physiologic testosterone administration increases lean body mass and improves quality of life among androgen-deficient men with the AIDS wasting syndrome.

Figures

Grahic Jump Location
Figure 1.
Flow of participants through the trial.

R = randomization.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Mean change ± SE for fat-free mass assessed by dual-energy x-ray absorptiometry, lean body mass determined from total-body potassium content, and muscle mass from urinary creatinine excretion in patients who received testosterone (left) and patients who received placebo (right) over 6 months.PPn

* < 0.05 for the change from baseline between the testosterone group and placebo group by analysis of covariance. **  <0.01 for the change from baseline between the testosterone group and placebo group by analysis of covariance. = number of patients for whom paired baseline and end-of-study data are available.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)